Abstract
Introduction Hyperbaric oxygen (HBO) has been demonstrated to be useful as an adjunctive therapy for Crohn’s disease. In the present study, HBO was tested as a treatment for trinitrobenzenesulfonic acid–ethanol (TNBS-E)-induced distal colitis, and its effects were compared with dexamethasone therapy. Methods A total of 48 Sprague-Dawley rats were separated into six groups: the control, and those treated with vehicle, TNBS-E, HBO, dexamethasone, or combined HBO + dexamethasone. The HBO treatment group was exposed to 100% HBO at 2 ATM for 75 min twice daily at 6-h intervals in a HBO chamber, both on the day of colitis induction and 3 days thereafter. Treatment with intraperitoneal dexamethasone twice daily was started 1 h before the induction of colitis and was continued for 7 days in the dexamethasone group. The rats were decapitated 8 days after the induction of colitis, and the colonic tissue wet weight, macroscopic and microscopic lesion score, and tissue myeloperoxidase (MPO) activity were determined. Results HBO therapy decreased the activity of experimental colitis measured by the tissue wet weight, macroscopic score, microscopic score, and MPO activity. The dexamethasone treatment significantly reduced the colitis activity as determined by the tissue MPO activity and wet weight. There were also decreases in the macroscopic and microscopic activity scores with the dexamethasone therapy; however, these changes were not statistically significant. The combined therapy with HBO and dexamethasone provided no additional benefit over HBO therapy alone. Conclusion HBO therapy can be a valuable therapeutic option in treatment of patients with inflammatory bowel disease. HBO therapy in the refractory patients deserves further, larger clinical studies.
Similar content being viewed by others
References
Rachmilewitz D, Karmeli F, Okon E, Rubenstein I, Better OS (1998) Hyperbaric oxygen: a novel modality to ameliorate experimental colitis. Gut 43:512–518
Hamzaoglu I, Karahasanoglu T, Aydın S, Sahin DA, Carkman S, Sarıyar M, Alemdaroglu K (1998) The effects of hyperbaric oxygen therapy on normal and ischemic colon anastomoses. Am J Surg 176:458–461
Basset BE, Bennett PB (1977) Introduction to the physical and physiological bases of hyperbaric oxygen therapy. In: Davis JC, Hunt TK (eds) Hyperbaric oxygen therapy. Undersea Medical Society, Bethesda, MD, 41, pp 11–24
Grim PS, Gottlieb LJ, Boddie A, Batson E (1990) Hyperbaric oxygen therapy. JAMA 263:2216–2220
Kindwall EP (1994) A history of hyperbaric medicine. In: Kindwall EP (ed) Hyperbaric medicine practice. Best Publishing Company, Arizona, pp 2–16
Mustoe TA, Porras-Reyes BH (1993) Modulation of wound healing response in chronic irradiated tissues. Clin Plast Surg 20:465–472
Zamboni WA, Roth AC, Russell RC, Nemiroff PM, Casas L, Smoot EC (1989) The effect of acute hyperbaric oxygen therapy on axial pattern skin flap survival when administered during and after total ischemia. J Reconstr Microsurg 5:343–347
Wattel F, Mathieu D, Coget JM, Billard V (1990) Hyperbaric oxygen therapy in chronic vascular wound management. Angiology 41:59–65
Oriani G, Meazza D, Favales F, Pizzi GL, Aldeghi A, Faglia E (1990) Hyperbaric oxygen therapy in diabetic gangrene. J Hyperb Med 5:171–175
Hammarlund C, Sundberg T (1994) Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double-blind study. Plast Reconstr Surg 93:829–833
Wallace JL, Whittle BJ, Boughton-Smith NK (1985) Prostaglandin protection of rat colonic mucosa from damage induced by ethanol. Dig Dis Sci 30:866–876
Empey LR, Jewell LD, Garg ML, Thomson AB, Clandinin MT, Fedorak RN (1991) Fish oil-enriched diet is mucosal protective against acetic acid-induced colitis in rats. Can J Physiol Pharmacol 69:480–487
Krawisz JE, Sharon P, Stenson WF (1984) Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87:1344–1350
Melamed Y, Shupak A, Bitterman H (1992) Medical problems associated with underwater diving. N Engl J Med 326:30–35
Tibbles PM, Edelsberg JS (1996) Hyperbaric-oxygen therapy. N Engl J Med 334:1642–1648
Lavy A, Weisz G, Adir Y, Ramon Y, Melamed Y, Eidelman S (1994) Hyperbaric oxygen for perianal Crohn’s disease. J Clin Gastroenterol 19:202–205
Rothfuss A, Dennog C, Speit G (1998) Adaptive protection against the induction of oxidative DNA damage after hyperbaric oxygen treatment. Carcinogenesis 19:1913–1917
Gulec B, Yasar M, Yildiz S, Oter S, Akay C, Deveci S, Sen D (2004) Effect of hyperbaric oxygen on experimental acute distal colitis. Physiol Res 53:493–499
Akin ML, Gulluoglu BM, Uluutku H, Erenoglu C, Elbuken E, Yildirim S, Celenk T (2002) Hyperbaric oxygen improves healing in experimental rat colitis. Undersea Hyperb Med 29:279–285
Gorgulu S, Yagci G, Kaymakcioglu N, Ozkara M, Kurt B, Ozcan A, Kaya O, Sadir S, Tufan T (2006) Hyperbaric oxygen enhances the efficiency of 5-aminosalicylic acid in acetic acid-induced colitis in rats. Dig Dis Sci 51:480–487
Dağlı Ü, Balk M, Yücel D, Ülker A, Över H, Saydam G, Şahin B (1997) The role of reactive oxygen metabolites in ulcerative colitis. Inflamm Bowel Dis 3:260–264
Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RW, Rowles PM, Lewis AA, Pounder RE (1989) Pathogenesis of Crohn’s disease: multifocal gastrointestinal infarction. Lancet 2:1057–1062
Tözün N, Hamzaoğlu HÖ (1997) İltihabi barsak hastalıklarında etyolojik faktörler. Güncel Gastroenteroloji 1/2:287–294
Bernstein LH, Frank MS, Brandt LJ, Boley SJ (1980) Healing of perianal Crohn’s disease with metronidazole. Gastroenterology 795:357–365
Rutgeerts P, Hiele M, Geboes K, Peeters M, Penninckx F, Aerts R, Kerremans R (1995) Controlled trial of metronidazole treatment for prevention of Crohn’s disease after ileal resection. Gastroenterology 108:1617–1621
Prantera C, Zannoni F, Scribano ML, Berto E, Andreoli A, Kohn A, Luzi C (1996) An antibiotic regimen for the treatment of active Crohn’s disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 91:328–332
Turunen UM, Farkkila MA, Hakala K, Seppala K, Sivonen A, Ogren M, Vuoristo M, Valtonen VV, Miettinen TA (1998) Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study. Gastroenterology 115:1072–1078
Weisz G, Lavy A, Adir Y, Melamed Y, Rubin D, Eidelman S, Pollack S (1997) Modification of in vivo and in vitro TNF α, IL-1 and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn’s disease. J Clin Immunol 17:154–159
Radermacher P, Frey G, Berger R (1997) Hyperbaric oxygen therapy—intensive care in a hostile environment. In: Vincent JL (ed) Yearbook of intensive care and emergency medicine. Springer, Berlin, pp 827–835
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Atug, O., Hamzaoglu, H., Tahan, V. et al. Hyperbaric Oxygen Therapy Is as Effective as Dexamethasone in the Treatment of TNBS-E-Induced Experimental Colitis. Dig Dis Sci 53, 481–485 (2008). https://doi.org/10.1007/s10620-007-9956-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-007-9956-4